Diadema Partners »

Eyepoint Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 285k 12.89

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Henderson Group
Vanguard Capital Management
Adage Capital Partners GP
Paradigm Biocapital Advisors
Commodore Capital
State Street Corporation
Citadel Advisors
Geode Capital Management
Standard Life Aberdeen
Balyasny Asset Management

View all funds holding Eyepoint Pharmaceuticals